WallStreetZenWallStreetZen

NASDAQ: ZYXI
Zynex Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ZYXI

Based on 2 analysts offering 12 month price targets for Zynex Inc

Min Forecast
$5.50+143.36%
Avg Forecast
$10.25+353.54%
Max Forecast
$15.00+563.72%

Should I buy or sell ZYXI stock?

Based on 2 analysts offering ratings for Zynex Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 50%
Hold
1 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ZYXI's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates ZYXI as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their ZYXI stock forecasts and price targets.

ZYXI stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-03-12
lockedlocked$00.00+00.00%2025-03-12

1 of 1

Forecast return on equity

Is ZYXI forecast to generate an efficient return?

Company
0.89%
Industry
356.31%
Market
75.61%
ZYXI's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ZYXI forecast to generate an efficient return on assets?

Company
0.26%
Industry
5.6%
ZYXI is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ZYXI earnings per share forecast

What is ZYXI's earnings per share in the next 2 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$0.49-644.44%
Avg 2 year Forecast
$0.01-88.89%

ZYXI revenue forecast

What is ZYXI's revenue in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
$135.0M-29.82%
ZYXI's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ZYXI revenue growth forecast

How is ZYXI forecast to perform vs Medical Distribution companies and vs the US market?

Company
-29.82%
Industry
9.04%
Market
58.64%
ZYXI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ZYXI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ZYXI vs Medical Distribution Stocks

TickerPricePrice TargetUp/downsideConsensus
ZYXI$2.26$10.25+353.54%Buy
EDAP$1.47$8.50+478.23%Buy
SNYR$2.36$10.00+323.73%Strong Buy
COSM$0.36N/AN/A
AHG$1.38N/AN/A
View Top Medical Distribution Stocks

Zynex Stock Forecast FAQ

Is Zynex Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: ZYXI) stock is to Buy ZYXI stock.

Out of 2 analysts, 0 (0%) are recommending ZYXI as a Strong Buy, 1 (50%) are recommending ZYXI as a Buy, 1 (50%) are recommending ZYXI as a Hold, 0 (0%) are recommending ZYXI as a Sell, and 0 (0%) are recommending ZYXI as a Strong Sell.

If you're new to stock investing, here's how to buy Zynex stock.

What is ZYXI's earnings growth forecast for 2025-2026?

(NASDAQ: ZYXI) Zynex's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Distribution industry's average forecast earnings growth rate of 77.44%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 72.53%.

Zynex's earnings in 2025 is $2,994,000.On average, 2 Wall Street analysts forecast ZYXI's earnings for 2025 to be -$15,637,119, with the lowest ZYXI earnings forecast at -$18,509,242, and the highest ZYXI earnings forecast at -$12,764,995.

In 2026, ZYXI is forecast to generate $319,125 in earnings, with the lowest earnings forecast at $319,125 and the highest earnings forecast at $319,125.

What is ZYXI's revenue growth forecast for 2025-2025?

(NASDAQ: ZYXI) Zynex's forecast annual revenue growth rate of -29.82% is not forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of 9.04%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.64%.

Zynex's revenue in 2025 is $192,354,000.

In 2025, ZYXI is forecast to generate $4,308,185,745 in revenue, with the lowest revenue forecast at $4,308,185,745 and the highest revenue forecast at $4,308,185,745.

What is ZYXI's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: ZYXI) forecast ROA is 0.26%, which is lower than the forecast US Medical Distribution industry average of 5.6%.

What is ZYXI's Price Target?

According to 2 Wall Street analysts that have issued a 1 year ZYXI price target, the average ZYXI price target is $10.25, with the highest ZYXI stock price forecast at $15.00 and the lowest ZYXI stock price forecast at $5.50.

On average, Wall Street analysts predict that Zynex's share price could reach $10.25 by Mar 12, 2026. The average Zynex stock price prediction forecasts a potential upside of 353.54% from the current ZYXI share price of $2.26.

What is ZYXI's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: ZYXI) Zynex's current Earnings Per Share (EPS) is $0.09. On average, analysts forecast that ZYXI's EPS will be -$0.49 for 2025, with the lowest EPS forecast at -$0.58, and the highest EPS forecast at -$0.40. In 2026, ZYXI's EPS is forecast to hit $0.01 (min: $0.01, max: $0.01).

What is ZYXI's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: ZYXI) forecast ROE is 0.89%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.